First Header Logo Second Header Logo

Connection

Joseph Jorizzo to Treatment Outcome

This is a "connection" page, showing publications Joseph Jorizzo has written about Treatment Outcome.
Connection Strength

0.734
  1. Aung-Din D, Heath M, Wechter T, Cline A, Feldman SR, Jorizzo JL. Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients With Geographic Tongue. JAMA Dermatol. 2018 12 01; 154(12):1481-1482.
    View in: PubMed
    Score: 0.093
  2. Yan BY, Jorizzo JL. Management of Morgellons Disease With Low-Dose Trifluoperazine. JAMA Dermatol. 2018 02 01; 154(2):216-218.
    View in: PubMed
    Score: 0.088
  3. Isak V, Jorizzo JL. Recent developments on treatment strategies and the prognosis of dermatomyositis: a review. J Dermatolog Treat. 2018 Aug; 29(5):450-459.
    View in: PubMed
    Score: 0.087
  4. Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatolog Treat. 2018 Mar; 29(2):197-199.
    View in: PubMed
    Score: 0.084
  5. Kwatra SG, Jorizzo JL. Bullous pemphigoid: a case series with emphasis on long-term remission off therapy. J Dermatolog Treat. 2013 Oct; 24(5):327-31.
    View in: PubMed
    Score: 0.058
  6. Neville JA, Williford PM, Jorizzo JL. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. J Drugs Dermatol. 2007 Sep; 6(9):910-4.
    View in: PubMed
    Score: 0.043
  7. Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, McRae S, Fielder S, Lee JH. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007 Aug; 57(2):265-8.
    View in: PubMed
    Score: 0.042
  8. Savin R, Jorizzo J. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Cutis. 2006 Oct; 78(4):268-74.
    View in: PubMed
    Score: 0.040
  9. Jorizzo J, Weiss J, Furst K, VandePol C, Levy SF. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004 Jul; 140(7):813-6.
    View in: PubMed
    Score: 0.034
  10. Jorizzo JL. Current and novel treatment options for actinic keratosis. J Cutan Med Surg. 2004; 8 Suppl 3:13-21.
    View in: PubMed
    Score: 0.033
  11. Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis. 2002 Dec; 70(6):335-9.
    View in: PubMed
    Score: 0.031
  12. Cline A, Cuellar-Barboza A, Jorizzo JL, Pichardo RO. Methotrexate for the Treatment of Recalcitrant Erosive Lichen Planus of the Vulva. JAMA Dermatol. 2020 02 01; 156(2):215-217.
    View in: PubMed
    Score: 0.025
  13. Moustafa FA, Sandoval LF, Jorizzo JL, Huang WW. Systemic treatment of papular dermatitis: A retrospective study. J Dermatolog Treat. 2015 Oct; 26(5):431-4.
    View in: PubMed
    Score: 0.018
  14. Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis. 2014 Nov; 94(5):255-9.
    View in: PubMed
    Score: 0.018
  15. Baartman B, Kosari P, Warren CC, Ali S, Jorizzo JL, Sato M, Kurup SK. Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet's syndrome). Dermatology. 2014; 228(3):193-7.
    View in: PubMed
    Score: 0.017
  16. Kaufman WS, McNamara EK, Curtis AR, Kosari P, Jorizzo JL, Krowchuk DP. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome. Pediatr Dermatol. 2012 Mar-Apr; 29(2):135-40.
    View in: PubMed
    Score: 0.014
  17. Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006 Dec; 55(6):1003-13.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.